Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Paul Bolno
Recent Posts
Colombia Oil and Gas 2023 Congress – Status and Developments Prospects of Oil and Gas industry in Latin America
Mike The Pike Productions, Inc. (OTC: MIKP) Announces Virtual Shareholder Conference July 25, 2023
Künstliche Intelligenz im Kinderherz-Zentrum
Auri Inc. – Dividend, Retirement Timelines and Expectations
Auto Parts 4Less Group, Inc. Unveils Significant Business Progress and Future Plans in Latest Investor Update
Sign Up To Get Our Instant Alerts!

Popular Post
-
Japanese Premier Declares COVID-19 State of Emergency in Tokyo 52 views
-
Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage 52 views
-
Expect Even More Unique Electric Cars Says Ferrari 44 views
-
Kimberly Goldwin Poised to Become Next President of ABC News 31 views
-
Records Show 19,000 U.S Based Amazon Employees Contracted Coronavirus 28 views